Market closed

Precision BioSciences/DTIL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Precision BioSciences

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Ticker

DTIL
Trading on

Industry

Biotechnology

Employees

110

DTIL Metrics

BasicAdvanced
$68M
Market cap
2.77
P/E ratio
$3.39
EPS
1.69
Beta
-
Dividend rate
$68M
1.69
$19.43
$8.25
54K
4.37
3.797
9.491
41.235
-3.19%
-2.62%
29.04%
2.771
0.533
0.9
0.9
-0.709
88.35%
-114.17%
-4.73%
-48.97%

What the Analysts think about DTIL

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Precision BioSciences stock.

DTIL Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DTIL Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy DTIL

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Precision BioSciences stock?

Precision BioSciences (DTIL) has a market cap of $68M as of October 05, 2024.

What is the P/E ratio for Precision BioSciences stock?

The price to earnings (P/E) ratio for Precision BioSciences (DTIL) stock is 2.77 as of October 05, 2024.

Does Precision BioSciences stock pay dividends?

No, Precision BioSciences (DTIL) stock does not pay dividends to its shareholders as of October 05, 2024.

When is the next Precision BioSciences dividend payment date?

Precision BioSciences (DTIL) stock does not pay dividends to its shareholders.

What is the beta indicator for Precision BioSciences?

Precision BioSciences (DTIL) has a beta rating of 1.69. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.